Suppr超能文献

经皮植入永久性腔静脉滤器:117例连续患者的随访

[Percutaneously implanted permanent vena cava filter: follow-up of 117 consecutive patients].

作者信息

Erpenbach S, Gerlach A, Arlart I P

机构信息

Radiologisches Institut, Katharinenhospital Stuttgart.

出版信息

Rofo. 1997 Sep;167(3):289-96. doi: 10.1055/s-2007-1015533.

Abstract

PURPOSE

Retrospective review of indication, insertion technique and problems, complications and effectiveness of 5 different filter designs implanted during a period of 5 years. MATERIALS, PATIENTS AND METHODS: We inserted one Filcard-filter, 4 Antheor DC 3 perm.-filters, 17 Trigon/Cardial-filters, 28 Titan-Greenfield-filters (modified hook) and 65 LGM 30 D/U Vena Tech-filters via a femoral (n = 111) or a jugular (n = 4) approach in 115 of 117 patients. Indication was acute deep thrombosis of the iliac or femoral vein with and without pulmonary embolism (PE) in patients with contraindication to, or unsuccessful, anticoagulation therapy or lysis. Follow-up was possible in 92 patients.

RESULTS

In two of 117 patients the filter could not be implanted due to dissection of the left iliac vein. In the other 115 patients we achieved an orthograde position of the filter in 78%, 22% of the filters tilted more than 15 zero and 25% had been opened incompletely. We noticed late filter dislocation in 4 cases, deep vein thrombosis of the access vein in two cases, one haematoma of the insertion site, three asymptomatic perforations of filter struts through the caval wall, 14 filter induced thromboses of the vena cava (15.2%) and 13 recurrent PE (14.1%), fatal in 5 cases (5.4%).

CONCLUSION

The implantation of vena caval filters as a prophylaxis of PE is easy and of low risk. Because of the relatively high rate of recurrent PE (14.1%) in our series after implantation, the effectiveness must be judged critically.

摘要

目的

回顾性分析5种不同滤器设计在5年期间植入的适应证、植入技术、问题、并发症及有效性。材料、患者与方法:我们对117例患者中的115例,经股静脉途径(n = 111)或颈静脉途径(n = 4)植入了1枚Filcard滤器、4枚Antheor DC 3永久滤器、17枚Trigon/Cardial滤器、28枚Titan - Greenfield滤器(改良钩型)和65枚LGM 30 D/U Vena Tech滤器。适应证为髂股静脉急性深静脉血栓形成,伴或不伴肺栓塞(PE),患者存在抗凝治疗禁忌证或抗凝治疗失败或溶栓治疗失败。92例患者获得随访。

结果

117例患者中有2例因左髂静脉解剖变异未能植入滤器。在其他115例患者中,78%的滤器位置正常,22%的滤器倾斜超过15度,25%的滤器未完全打开。我们发现4例滤器晚期移位,2例穿刺静脉发生深静脉血栓,1例穿刺部位血肿,3例滤器支脚无症状性穿透腔静脉壁,14例发生滤器导致的腔静脉血栓形成(15.2%),13例发生复发性PE(14.1%),其中5例死亡(5.4%)。

结论

植入腔静脉滤器预防PE操作简便且风险低。由于我们系列研究中植入后复发性PE发生率相对较高(14.1%),其有效性必须审慎判断。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验